Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/12/2025

Contraception and Hypersexuality Management

Introduction to Liletta IUD

  • The Liletta IUD is a 52 mg levonorgestrel-releasing intrauterine device with approved indications for highly effective contraception (failure rate <1%) and is approved for up to 3 years of use, according to the American Academy of Pediatrics 1

Approved Indications for Liletta IUD

  • The Liletta IUD is highly effective for contraception, with a failure rate of less than 1%, and may help with menstrual symptoms by reducing overall bleeding, leading to amenorrhea in some users, and improving painful menses, as recommended by the American College of Obstetricians and Gynecologists 1

Management of Hypersexuality

  • Hypersexuality should be approached as a symptom of an underlying condition rather than as a standalone disorder, requiring comprehensive assessment to identify underlying causes, including evaluation for comorbid psychopathological conditions, assessment for organic medical conditions, and review of current medications that may affect sexual behavior 1